Jillian C. Bensko

Prostaglandin D2: A dominant mediator of aspirin-exacerbated respiratory disease

Katherine N. Cahill, Jillian C. Bensko, Joshua A. Boyce et al. · Journal of Allergy and Clinical Immunology · 2014 · 226 citations · Full text

Asthma, Inflammation, Anti-inflammatory +9

Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production

Yuezhou Chen, Adam Zuiani, Stephanie Fischinger et al. · Cell · 2020 · 207 citations · Full text

Covid-19 Pandemic, Immunology, Virology +2

Mepolizumab targets multiple immune cells in aspirin-exacerbated respiratory disease

Kathleen M. Buchheit, Erin I. Lewis, Deborah Gakpo et al. · Journal of Allergy and Clinical Immunology · 2021 · 76 citations · Full text

Inflammation, Asthma, Anti-inflammatory +8

Rapid and sustained effect of dupilumab on clinical and mechanistic outcomes in aspirin-exacerbated respiratory disease

Kathleen M. Buchheit, Aaqib Sohail, Jonathan Hacker et al. · Journal of Allergy and Clinical Immunology · 2022 · 71 citations · Full text

Asthma, Translational Medicine, Mechanistic Outcomes +11

Efficacy of dupilumab in patients with aspirin-exacerbated respiratory disease and previous inadequate response to anti-IL-5 or anti-IL-5Rα in a real-world setting

Nicole Bavaro, Deborah Gakpo, Anisha Mittal et al. · The Journal of Allergy and Clinical Immunology In Practice · 2021 · 39 citations · Full text

Inflammation, Asthma, Rheumatology +13